ADMA Biologics, Inc.ADMANASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-9.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-27.06%
2024753.85%
202369.77%
202229.51%
202140.20%
20202.86%
201927.59%
201824.08%
2017-18.63%
20166.94%